New Triazine Derivatives as Serotonin 5-HT


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
22 Jan 2023
Historique:
received: 30 11 2022
revised: 18 01 2023
accepted: 19 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Since the number of people with Alzheimer's disease (AD) continues to rise, new and effective drugs are urgently needed to not only slow down the progression of the disease, but to stop or even prevent its development. Serotonin 5-HT

Identifiants

pubmed: 36770774
pii: molecules28031108
doi: 10.3390/molecules28031108
pmc: PMC9919591
pii:
doi:

Substances chimiques

Serotonin 333DO1RDJY
serotonin 6 receptor 0
Receptors, Serotonin 0
Ligands 0
Triazines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Center (Poland)
ID : UMO-2018/31/B/NZ7/02160

Références

Pharm Res. 2008 Jul;25(7):1511-20
pubmed: 18185985
Eur J Med Chem. 2022 Dec 5;243:114761
pubmed: 36179403
Eur J Med Chem. 2017 Jul 28;135:117-124
pubmed: 28441580
Molecules. 2021 Jul 29;26(15):
pubmed: 34361754
Molecules. 2018 Oct 03;23(10):
pubmed: 30282913
Neurosci Biobehav Rev. 2022 Aug;139:104729
pubmed: 35691469
Bioorg Chem. 2022 Apr;121:105695
pubmed: 35228010
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Apr;72(Pt 2):171-9
pubmed: 27048719
Molecules. 2018 Jul 14;23(7):
pubmed: 30011904
Bioorg Med Chem Lett. 2021 Oct 1;49:128275
pubmed: 34311086
Eur J Med Chem. 2019 Sep 15;178:740-751
pubmed: 31229876
BMJ. 2021 Jun 11;373:n1503
pubmed: 34117086
J Appl Crystallogr. 2020 Feb 01;53(Pt 1):226-235
pubmed: 32047413
Int J Mol Sci. 2021 May 10;22(9):
pubmed: 34068678
Medchemcomm. 2018 May 14;9(6):951-962
pubmed: 30108984
Bioorg Chem. 2019 Mar;84:319-325
pubmed: 30530073
Lancet. 2021 Apr 24;397(10284):1577-1590
pubmed: 33667416
J Prev Alzheimers Dis. 2021;8(4):398-410
pubmed: 34585212
Eur J Med Chem. 2020 Oct 1;203:112529
pubmed: 32693296
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8
pubmed: 25567568
Int J Mol Sci. 2019 Jul 12;20(14):
pubmed: 31336820
Bioorg Med Chem. 2016 Sep 15;24(18):4347-4362
pubmed: 27485602
Neuropharmacology. 2017 Oct;125:50-63
pubmed: 28711518
J Alzheimers Dis. 2020;75(4):1329-1338
pubmed: 32417774
Expert Opin Investig Drugs. 2018 Jun;27(6):523-533
pubmed: 29848076
Alzheimers Dement (N Y). 2022 May 04;8(1):e12295
pubmed: 35516416
Int J Mol Sci. 2021 Oct 05;22(19):
pubmed: 34639113
Pharmaceutics. 2022 May 24;14(6):
pubmed: 35745693
Eur J Med Chem. 2014 Aug 18;83:534-46
pubmed: 24996140

Auteurs

Dorota Łażewska (D)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.

Małgorzata Więcek (M)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.

Grzegorz Satała (G)

Department of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.

Paulina Chałupnik (P)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.

Ewa Żesławska (E)

Institute of Biology, Pedagogical University of Krakow, Podchorążych 2, 30-084 Kraków, Poland.

Ewelina Honkisz-Orzechowska (E)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.

Monika Tarasek (M)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.

Gniewomir Latacz (G)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.

Wojciech Nitek (W)

Faculty of Chemistry, Jagiellonian University in Kraków, Gronostajowa 2, 30-387 Kraków, Poland.

Ewa Szymańska (E)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.

Jadwiga Handzlik (J)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH